LI
PCVX icon

LRI Investments’s Vaxcyte PCVX Stock Holding History

LRI Investments’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$58 Buy
+1
New +$54 ﹤0.01% 1896

Other funds holding PCVX

Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
NFT
Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
BPC
Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

LRI Investments's PCVX Position: Q2 2026 in Review

LRI Investments opened a new position in Vaxcyte (PCVX) in Q2 2026: 1 share worth $58. The stake represents ﹤0.01% of the portfolio and ranks #1896 among its holdings.

64 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

  • LRI Investments held 1 share of Vaxcyte worth $58 as of Q2 2026.
  • Vaxcyte was a new LRI Investments position in Q2 2026.
  • Vaxcyte made up ﹤0.01% of LRI Investments's portfolio in Q2 2026, its #1896 holding.
  • 64 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on LRI Investments's 13F filing for Q2 2026, filed 14 Jul 2026.